172 related articles for article (PubMed ID: 19923475)
1. Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.
Li L; Mahan CS; Palaci M; Horter L; Loeffelholz L; Johnson JL; Dietze R; Debanne SM; Joloba ML; Okwera A; Boom WH; Eisenach KD
J Clin Microbiol; 2010 Jan; 48(1):46-51. PubMed ID: 19923475
[TBL] [Abstract][Full Text] [Related]
2. Assessment of messenger RNA (mRNA) of Mycobacterium tuberculosis as a marker of cure in patients with pulmonary tuberculosis.
Montenegro RA; Guarines KM; Montenegro LM; Lira LA; Falcão J; Melo FL; Santos FC; Nascimento AL; Zuzarte MS; Leite RC; Schindler HC
J Appl Microbiol; 2014 Jul; 117(1):266-72. PubMed ID: 24684542
[TBL] [Abstract][Full Text] [Related]
3. Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum.
Mdivani N; Li H; Akhalaia M; Gegia M; Goginashvili L; Kernodle DS; Khechinashvili G; Tang YW
Clin Chem; 2009 Sep; 55(9):1694-700. PubMed ID: 19574468
[TBL] [Abstract][Full Text] [Related]
4. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.
Desjardin LE; Perkins MD; Wolski K; Haun S; Teixeira L; Chen Y; Johnson JL; Ellner JJ; Dietze R; Bates J; Cave MD; Eisenach KD
Am J Respir Crit Care Med; 1999 Jul; 160(1):203-10. PubMed ID: 10390401
[TBL] [Abstract][Full Text] [Related]
5. Day zero quantitative mRNA analysis as a prognostic marker in pulmonary tuberculosis category II patients on treatment.
Singh UB; Rana T; Kaushik A; Porwal C; Makkar N
Clin Microbiol Infect; 2012 Nov; 18(11):E473-81. PubMed ID: 23005345
[TBL] [Abstract][Full Text] [Related]
6. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity.
Kayigire XA; Friedrich SO; Venter A; Dawson R; Gillespie SH; Boeree MJ; Heinrich N; Hoelscher M; Diacon AH;
J Clin Microbiol; 2013 Jun; 51(6):1894-8. PubMed ID: 23596237
[TBL] [Abstract][Full Text] [Related]
8. Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
McAulay K; Saito K; Warrier T; Walsh KF; Mathurin LD; Royal-Mardi G; Lee MH; Ocheretina O; Pape JW; Fitzgerald DW; Nathan CF
mBio; 2018 Nov; 9(6):. PubMed ID: 30459198
[TBL] [Abstract][Full Text] [Related]
9. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
[TBL] [Abstract][Full Text] [Related]
10. Detection of Mycobacterium tuberculosis directly from sputum specimens & phenotypic drug resistance pattern of M. tuberculosis isolates from suspected tuberculosis patients in Chennai.
Therese KL; Gayathri R; Dhanurekha L; Sridhar R; Meenakshi N; Madhavan HN; Manoj SE; Vinayagam AK
Indian J Med Res; 2012 May; 135(5):778-82. PubMed ID: 22771612
[TBL] [Abstract][Full Text] [Related]
11. Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.
Diacon AH; Maritz JS; Venter A; van Helden PD; Andries K; McNeeley DF; Donald PR
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1561-5. PubMed ID: 20820832
[TBL] [Abstract][Full Text] [Related]
12. Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
Bark CM; Gitta P; Ogwang S; Nsereko M; Thiel BA; Boom WH; Eisenach KD; Joloba ML; Johnson JL
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1448-51. PubMed ID: 24125449
[TBL] [Abstract][Full Text] [Related]
13. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
[TBL] [Abstract][Full Text] [Related]
14. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
Diacon AH; Dawson R; von Groote-Bidlingmaier F; Symons G; Venter A; Donald PR; van Niekerk C; Everitt D; Winter H; Becker P; Mendel CM; Spigelman MK
Lancet; 2012 Sep; 380(9846):986-93. PubMed ID: 22828481
[TBL] [Abstract][Full Text] [Related]
15. Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.
Furin JJ; Du Bois J; van Brakel E; Chheng P; Venter A; Peloquin CA; Alsultan A; Thiel BA; Debanne SM; Boom WH; Diacon AH; Johnson JL
Antimicrob Agents Chemother; 2016 Nov; 60(11):6591-6599. PubMed ID: 27550361
[TBL] [Abstract][Full Text] [Related]
16. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Ambreen A; Jamil M; Rahman MAU; Mustafa T
BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments.
Kayigire XA; Friedrich SO; van der Merwe L; Donald PR; Diacon AH
Tuberculosis (Edinb); 2015 Dec; 95(6):770-779. PubMed ID: 26318558
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
[TBL] [Abstract][Full Text] [Related]
19. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
20. Nested reverse transcriptase-polymerase chain reactions targeting the messenger RNA of icl2, hspx, and rRNAP1 genes to detect viable Mycobacterium tuberculosis directly from clinical specimens.
Lakshmipathy D; Kulandai LT; Ramasubban G; Hajib Narahari Rao M; Rathinam S; Narasimhan M
Int J Mycobacteriol; 2015 Dec; 4(4):312-7. PubMed ID: 26964814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
